The aetiological agent of Lyme disease, Borrelia burgdorferi cycles between its tick vector and mammalian hosts, implying that it can sense different environments and consequently change the expression of genes encoding several surface-associated proteins. The genome of the type strain B. burgdorferi B31 has revealed 175 different gene families. The p13 gene, situated on the chromosome, encodes a channel-forming protein that belongs to the gene family 48 consisting of eight additional paralogous genes. The heterogeneity of the P13 protein from different Lyme disease Borrelia strains was investigated. The predicted surface-exposed domains are the most heterogeneous regions and contain probable epitopes of P13. The membrane-spanning architecture of P13 was determined and a model for the location of this protein in the outer membrane is presented. The transcription of the paralogues of gene family 48 during in vitro culturing and in a mouse infection model was also analysed. The bba01 gene is the only p13 paralogue present in all three Lyme-disease-causing genospecies; it is stable during cultivation in vitro and the BBA01 protein was expressed in all Borrelia strains investigated. Conversely, paralogues bbi31, bbq06 and bbh41 were only detected in B. burgdorferi and the corresponding plasmids harbouring bbi31 and bbh41 were lost during in vitro passage. Finally, p13 and bbi31 are the only members of gene family 48 that are transcribed in mice, suggesting their importance during mammalian infection.
INTRODUCTION
Borrelia burgdorferi is a tick-transmitted spirochaete that causes Lyme borreliosis, a disease characterized by dermatological, rheumatological, cardiac and neurological manifestations (Steere, 1989) . There are three genospecies of Borrelia that can cause Lyme borreliosis in humans, B. burgdorferi, B. afzelii and B. garinii. B. burgdorferi has an unusual genome consisting of a linear chromosome of 910 kb and 21 plasmids (12 linear and 9 circular) giving an additional 611 kb (Casjens et al., 2000; Fraser et al., 1997) . Previous studies have shown that several B. burgdorferi plasmids are important for infectivity (Hefty et al., 2002; Purser et al., 2003; Purser & Norris, 2000; Schwan et al., 1988a; Thomas et al., 2001) . Culture passages of B. burgdorferi are associated with loss of plasmids (Barbour, 1988) and thereby loss of infectivity Schwan et al., 1988a; Xu et al., 1996) . The B. burgdorferi B31 genome contains 175 gene families. Most of the paralogous genes within these families are situated on plasmids. Those gene families that already have been investigated include bdr (Carlyon et al., 2000; Zuckert et al., 1999) , bmp (Aron et al., 1994; Gorbacheva et al., 2000; Ramamoorthy et al., 1996; Simpson et al., 1994) , elp (Akins et al., 1999; Hefty et al., 2001) , erp (Stevenson et al., 1996 (Stevenson et al., , 1998a (Stevenson et al., , b, 2002 , mlp (Porcella et al., 2000; Yang et al., 1999 Yang et al., , 2000 , family 95 (bapA and eppA) (Miller & Stevenson, 2003) and vls (Wang et al., 2001; Zhang et al., 1997; Zhang & Norris, 1998a, b) . In B. burgdorferi B31, there are nine members of gene family 48 with the sequence identity to p13 ranging from 28?6 % for bbj03 to 40?9 % for bba01 (Casjens et al., 2000; Fraser et al., 1997) . One member, the chromosomally encoded, channel-forming outer-membrane protein P13 has been thoroughly investigated (Nilsson et al., 2002; Noppa et al., 2001; Ö stberg et al., 2002) , and is among only a few integral membrane proteins characterized in B. burgdorferi (Bunikis et al., 1995; Carroll et al., 2001; Noppa et al., 2001; Skare et al., 1996) . Since this gene family has not been identified in any other bacteria beside the genus Borrelia, the genes might encode proteins important for the infectious cycle of Lyme borreliosis spirochaetes.
In this study we investigated the heterogeneity of the p13 gene from all species causing Lyme borreliosis. Significantly, the most heterogeneous, surface-exposed region of P13 appeared to be the natural epitope. Furthermore, we combined epitope mapping with computer-based predictions to determine the membrane-spanning architecture of P13 in the outer membrane. The presence of the other paralogous genes of family 48 in a number of different Borrelia strains was also examined, and transcription of p13 and three of its paralogues (bba01, bbi31, bbh41) was investigated both under normal culture conditions and during infection in mice. Expression of the paralogue BBA01 in Lyme disease Borrelia was also investigated in vitro.
METHODS
Bacterial strains and growth conditions. The Borrelia strains used are listed in Table 1 . Spirochaetes were grown in either BSK-H (Sigma) or BSK-II (Barbour, 1984 ) medium supplemented with 6 % rabbit serum (Sigma) at 32 uC until cell density reached approximately 10 7 -10 8 cells ml 21 , after which the cell culture was pelleted for protein, DNA or RNA preparation.
Escherichia coli strains TOP10 (Invitrogen), DH5a (Invitrogen) and Rosetta (DE3)pLysS (Novagen) were used for cloning and expression. These strains were grown in Luria-Bertani (LB) liquid medium or agar Primers Y12 and Y18 (Noppa et al., 2001) were used for amplification of the p13 gene. For amplification of bba01, bbi31 and bbh41, the primer combinations of A01-M2 with A01-M2Rev, I31-M2 with I31-M2Rev, and H41-M2 with H41-M2Rev were used respectively ( Table 2 ). Every PCR reaction was repeated twice to ensure the validity of the results. For sequencing, the p13 and bba01 PCR products were cloned into pGEM-T Easy vector (Promega) and maintained in DH5a. Plasmids were prepared using the Qiaprep Spin miniprep kit (Qiagen) and sequencing was performed using the BigDye Kit (Perkin Elmer) and an Applied Biosystems ABI 377 Sequencer. The sequences were analysed using GCG [Wisconsin Package Version 9.1, Genetics Computer Group (GCG)] software and alignment of the consensus sequences was obtained using the BioEdit program (Tom Hall, Department of Microbiology, North Carolina State University).
Detection of plasmids lp28-3 and lp28-4. B. burgdorferi strains B31, N40 and Sh2-82 were initially grown from low passage (approx. passage 4) and then subsequently cultivated by adding 1 ml of the culture in exponential growth phase (~10 7 cells ml
21
) to 12 ml of BSK-II medium. The presence of the paralogous gene sequences and corresponding plasmids was determined by PCR in each passage using PCR conditions as described above. The primers used for amplification of the lp28-3 and lp28-4 plasmids were H-M4 with H-M4Rev and I-M4 with I-M4Rev respectively (Table 2) . PCR reaction using the same reaction conditions as described above. PCR products were analysed on a 1 % TBE-agarose gel stained with ethidium bromide (5 mg ml 21 ).
Mouse infection. B. burgdorferi strain B31 was used for mouse infections. Prior to infection, the presence of the query genes in B31 was confirmed by PCR. Four-week-old C3H/HeN mice (Bomholt Gård Breeding, Denmark) were subcutaneously injected with 10 5 spirochaetes in 0?1 ml culture medium. The number of bacteria was determined microscopically in a Petroff-Hausser chamber. Negative controls were injected with 0?1 ml BSK-II medium. Three weeks post-infection, the mice were anaesthetized by injection of a mixture of Dormicum (Roche), Hypnorm (Janssen Pharmaceutica) and water (1 : 1 : 2), and killed by cardiac puncture. Ears, heart and bladder were aseptically removed and one ear and heart were immediately frozen in liquid nitrogen. The other ear and bladder were added to BSK-II medium supplemented with sulfamethoxazole (1?25 ml ml 21 ) and phosphomycin (4 ml ml 21 ) for detection of Borrelia spirochaetes. Isolation of RNA and RT-PCR. All reagents were prepared with diethylpyrocarbonate (DEPC)-treated water. Total RNA was isolated from in vitro-cultured Borrelia using the Ultraspec-II RNA isolation system (Biotex Laboratories) or Trizol reagent (Invitrogen) and from mouse heart with Trizol reagent essentially according to the manufacturer's instructions. Aliquots (2 mg) of each RNA preparation were then treated with 3 units of RNase-free DNaseI (Roche) to remove contaminating DNA.
Both 2-step and 1-step RT-PCR were used in this study. First-strand cDNA reactions were primed with 5 pmol gene-specific primer (Table 2 ) and synthesized using the AMV reverse transcriptase (Roche). For gene-specific PCR amplification from cDNA, 5 ml of first-strand cDNA reaction was amplified in a total volume of 50 ml, containing 20 nM of each primer, 200 mM of each dNTP and 0?5 units of Taq DNA polymerase. For 1-step RT-PCR from the 1 mg of RNA, the Superscript One-Step RT-PCR with Platinum Taq kit (Invitrogen) was used following the manufacturer's instructions. In each RT-PCR, two negative controls were included: sterile water to verify the purity of the reagents, and RNA from uninfected mice to confirm the reaction specificity and the absence of cross-contamination during sample processing. Using DNA extracted from B. burgdorferi cultures we monitored amplification efficiency. Two additional positive controls were included: primers specific for the mouse housekeeping gene hypoxanthine-guanine phosphoribosyl transferase (HPRT) (Pinto do et al., 1998) were used to monitor RT-PCR efficiency on RNA preparations from organs, and the flagella-specific flaB primers FB1 and FB2 (Noppa et al., 2001) were used for Borrelia RNA detection. For all 1-step RT-PCR reactions the absence of DNA contamination was verified by PCR. Ten microlitres of each RT-PCR product was analysed on 1 % TBE-agarose gel stained with ethidium bromide (5 mg ml
).
Protein electrophoresis, immunoblotting and antibodies.
Proteins were separated in Tricine 10-20 % polyacrylamide gradient gels or in Bistris 4-12 % polyacrylamide gradient NuPage gels by using the Novex XCell Sure Lock electrophoresis cell (Invitrogen). Total Borrelia proteins were prepared by growing cells to stationary phase, harvesting by centrifugation at 8000 g at 4 uC, and washing twice in phosphate-buffered saline (PBS). The outer-membrane proteins (B-fraction) of B. burgdorferi strain B31 were prepared as described elsewhere (Magnarelli et al., 1989) . For immunoblotting, proteins were transferred to a PVDF membrane (PALL Corp.) and probed with antibodies. The polyclonal antibody recognizing P13 is described elsewhere (Noppa et al., 2001) . For production of serum against the BBA01 protein, a synthetic peptide with the sequence EKGIESFNKYDKEKC (amino acids 28-41 plus a terminal cysteine) was used (obtained from Innovagen). The peptide fragment was conjugated to a keyhole limpet haemocyanin (KLH) carrier via its terminal cysteine with maleimide cross-linker (Agrisera). The synthetic peptide was used for immunizing a rabbit and an immune serum was obtained (Agrisera). The monoclonal antibody (mAb) 15G6, recognizing P13, was previously described . Bound antibodies were detected using peroxidase-conjugated anti-rabbit or anti-mouse antibodies (DAKO) and enhanced chemiluminescence (ECL) reagents according to the manufacturer's instructions (Amersham Pharmacia Biotech).
Overexpression of different P13 fragments. Three fragments (A, B and C) covering the sequence of mature P13 were obtained using the primer pairs P13M1F with Y54MR (A), Y55MF with Y56MR (B), and Y57MF with P13M1R (C). All primer sequences are given in Table 2 ; the restriction sites included were: Acc65I for primers P13M1R, Y54MR and Y56MR, BspHI for primers Y55MF and Y57MF, and NcoI for primer P13M1F. The PCR conditions used were as follows: 5 cycles at 94 uC for 30 s, 45 uC for 1 min, 72 uC for 1 min and 35 cycles at 94 uC for 30 s, 55 uC for 1 min and 72 uC for 1 min. The PCR products were further purified using High Pure PCR Product Purification Kit (Roche) columns; fragments B and C were digested with Acc65I and BspHI restriction enzymes, whereas fragment A was digested with Acc65I and NcoI restriction enzymes (New England Biolabs). Thereafter, the PCR products were cloned in pETM-20 vector (EMBL, Heidelberg, Germany) digested with Acc65I and BspHI and transformed into E. coli TOP10. Colonies were screened for the correct inserts and plasmids containing the three different fragments of the p13 gene (A, B and C) were purified using the Qiaprep plasmid miniprep kit (Qiagen) and transformed into Rosetta (DE3)pLysS cells for protein expression. After 3 h induction, the cultures were harvested by centrifugation at 8000 g for 5 min, resuspended in 200 ml PBS, and the protein concentration was estimated using Bio-Rad Protein Assay kit. Protein samples (10 mg) were then analysed on 4-12 % Bistris acrylamide gels and stained with Coomassie G-250. Epitope mapping was performed using Western blotting and mAb 15G6.
RESULTS

Analysis of the p13 gene and its paralogues in different Borrelia species
The p13 (bb0034) gene belongs to the paralogous gene family 48 with nine members (Table 3) . Unlike p13, all the paralogues are plasmid encoded. Moreover, bbg03 has an authentic frameshift, bbj02.1 and bbq81 are considered to be pseudogenes and bbj03 is located inside the bbj02.1 gene (Casjens et al., 2000; Fraser et al., 1997) . We have earlier noted that four of the paralogous genes (bba01, bbi31, bbh41 and bbq06) show more significant sequence similarities with the p13 gene (Noppa et al., 2001 ) and we therefore chose these for further investigation.
We analysed the presence of p13 and its paralogous genes in different Borrelia species using PCR amplification of the p13, bba01, bbi31, bbh41 and bbq06 genes ( Table 1) . The p13 gene was detected in all species investigated with the exception of the avian borreliosis agent B. anserina (Table 1 ). The bba01 paralogue was detected in all Lyme disease species and all Lyme-disease-related species except B. valaisiana, B. tanukii and B. lusitaniae (Table 1) . Interestingly, the bbi31 and bbh41 genes only appear to be present in B. burgdorferi strains. Within this strain collection, however, bbi31 is not detected in strains B31-A and B313, while bbh41 was absent in strain B313 and N40.
These two paralogues are situated on the linear plasmids lp28-4 and lp28-3 respectively, which we estimated are lost after about 25 cultivation passages of Borrelia spirochaetes in vitro (data not shown).
Given the widespread distribution of the p13 allele within Lyme disease Borrelia species and strains, the heterogeneity among the P13 protein was investigated. Amino acid sequence comparison of P13 revealed that it is considerably homogeneous and that most sequence heterogeneity is found outside the predicted transmembrane regions, especially between the transmembrane regions III and IV (Fig. 1) . This observation is consistent with the probable surface exposure of these regions of P13, as is considered to be true also for the corresponding parts of the paralogue proteins within family 48 (Noppa et al., 2001) . Additionally, the most sequence heterogeneity of P13 is found between species. P13 of the B. garinii strains was found to be the least well conserved, as expected, since this genospecies is the most heterogeneous of all Lyme disease Borrelia spp. . We also analysed the sequence heterogeneity of the bba01 from different Lyme disease Borrelia strains by sequencing an internal region (located at nucleotide position 60-313) of the gene. The bba01 gene was very homogeneous, with only minor heterogeneity between species (data not shown).
Epitope mapping of P13
To investigate the architecture of P13 and elucidate the natural epitope of the protein, we performed epitope mapping of the P13 protein derived from B. burgdorferi B31. Based upon the assumption that the most heterogeneous region of the protein is the outer-surface-exposed epitope, we expressed three fragments of mature P13 located at amino acid positions 20-92 (fragment A), 86-119 (fragment B) and 114-151 (fragment C). The expression vector of choice was pETM-20, which contains a His-tag, a recombinant tobacco etch virus (rTEV) protease cleavage site and a thioredoxin reductase (TrxA) fusion protein.
Expressed proteins were detected on a Coomassie-stained gel (Fig. 2a) , and by immunoblotting with mAb 15G6 (Fig. 2b ). This antibody is supposed to recognize the natural epitope of the protein . Indeed, mAb 15G6 recognized only the fragment of P13 which covers the predicted surface-exposed region, fragment B (Fig. 2b,  lane 3) . The other two fragments were not recognized, presumably because these correspond to transmembrane regions with only a short surface-exposed domain (fragment A) and a short domain that is directed into the periplasmic space (fragment C) (Fig. 2b, lanes 1 and 4) . Interestingly, the polyclonal sera against P13 (Noppa et al., 2001 ) recognized only fragments A and C, but not the surface-exposed epitope (fragment B) (data not shown). This indicates that the polyclonal antibody raised against purified P13 does not necessarily recognize the natural epitope of the protein. This result is consistent with our finding that this polyclonal rabbit antiserum does not recognize P13 of intact B. burgdorferi, but binds to P13 only when the outer membrane is permeabilized (data not shown). Based on these results we have proposed a model illustrating how P13 is located in the outer membrane of Borrelia (Fig. 3) . This prediction also combines computer analysis of the transmembranespanning domains using the webserver SOSUI system (http://sosui.proteome.bio.tuat.ac.jp/sosuiframe0.html), secondary structure prediction using the webservers TMHMM (http://www.cbs.dtu.dk/services/TMHMM-2.0/) and PSORT (http://psort.nibb.ac.jp/form.html), and our previous published results (Noppa et al., 2001) .
RT-PCR analysis of the B. burgdorferi gene family 48 in culture and mice
The presence of transcripts from p13 and its paralogous genes (bba01, bbi31, bbh41 and bbq06) was investigated by RT-PCR from different in vitro-cultivated B. burgdorferi strains (Table 4) . To study the expression of p13 and its paralogues in mice, low-passage, infectious strain B31 was used. Three weeks after infection, the presence of B. burgdorferi in organs was analysed by in vitro culturing of tissue samples from ear and urinary bladder and subsequent microscopy screening (data not shown). Using PCR, we also investigated if the p13 gene and its paralogous gene sequences were present in B. burgdorferi cultivated from mouse organs (data not shown). Two out of eight B. burgdorferi B31 infected mice were chosen for further experiments, and RNA from heart tissue was used for RNA preparation and subsequent RT-PCR analysis. The RT-PCR analysis revealed that p13 and bbi31 are expressed both in laboratory culture (Table 4 ) and in mice (Table 5) , whereas bba01 and bbh41 were only expressed in culture and their expression was below the detectable level in mice (Tables 4  and 5 ).
Analysis of BBA01 expression in different strains of Lyme disease Borrelia
Since the bba01 gene exhibits most sequence identity (40?9 %) to p13 and was detected in all Lyme disease species, the expression of BBA01 protein in cultures of Lyme disease Borrelia was investigated using polyclonal rabbit antiserum raised against BBA01 (Fig. 4) . For immunization, a synthetic peptide to a probable outer-surfaceexposed region of BBA01 situated between the two computer-predicted transmembrane regions II and III was used (data not shown). The immunoblot reveals that the identified BBA01 protein is smaller than theoretically calculated (17?8 kDa) using the website http://www.expasy. org/tools/tagident.html (Appel et al., 1994) . Thus, BBA01 seems to be processed similarly to P13 (Noppa et al., 2001) . Our experiment shows that BBA01 seems to be produced only in low-passage strain B31, although the gene was detected in high-passage B31 (Table 4) . As expected, BBA01 was not produced in strain B313, since this strain lacks lp54. Interestingly, we could not detect BBA01 in the outer-membrane fraction of B. burgdorferi B31 (Fig. 4 , The bold line shows the proteolytically cleaved, mature P13 in the outer membrane. mAb 15G6 is shown schematically to specifically recognize the surface-exposed epitope of P13. 
B31 (control from culture before infection) Fig. 4 . Western blot analysis of BBA01 expressed in Lyme disease Borrelia. Ten micrograms of total protein was separated on 10-20 % Tricine gel, blotted onto a PVDF membrane and probed with rabbit immune serum against BBA01. Lanes: 1, total protein of low-passage B31 (8 passages); 2, outermembrane fraction of low-passage B31 (9 passages); 3, total protein of high-passage B31 (>100 passages); 4, total protein of strain B313; 5, total protein of strain B31-A; 6, total protein of strain P13-18; 7, total protein of B. afzelii ACAI; 8, total protein of B. garinii Ip90. Molecular size in kDa is indicated to the left.
lane 2). However, in the p13 knockout mutant P13-18 (Ö stberg et al., 2002), BBA01 production was significantly upregulated compared to the isogenic wild-type strain B31-A (Fig. 4, lanes 5 and 6) . Moreover, the highest production of BBA01 was in the low-passage B. afzelii ACAI (Fig. 4, lane 7) , but is also present in low-passage B. garinii Ip90 (Fig. 4, lane 8) . This suggests that the BBA01 paralogue plays an important role in all three species of Lyme disease Borrelia.
DISCUSSION
Previous studies have revealed that the P13 protein is an integral outer-membrane protein with surface-exposed domains (Noppa et al., 2001 ) and channel-forming activity (Ö stberg et al., 2002) . We therefore hypothesized that the computer-predicted outer-membrane-exposed domains should be the most heterogeneous regions of the protein.
We analysed the heterogeneity of the P13 protein from several different Lyme disease Borrelia strains to confirm that the predicted outer-surface-exposed domains are the most variable regions (Fig. 1) . We utilized an epitope mapping strategy to characterize the antigenic determinant of P13 and elucidate the possible membrane-spanning architecture of the protein. Consistent with in silico data, an expressed peptide encompassing the most diverse region of P13 (fragment B) was specifically detected with a monoclonal antibody (mAb 15G6) that apparently recognizes only the natural epitope of P13 protein (Fig. 2b , lane 3, and Sadziene et al., 1995) . Hence, we interpret this to indicate that the region composed of fragment B is surface exposed and serves as the natural epitope of the protein. Thus, a model was proposed for how P13 is situated in the outer membrane of Borrelia (Fig. 3) . mAb 15G6 strongly inhibits growth of B. burgdorferi strain B313, deficient in the major outer-surface proteins (Osps), but has no effect on the growth of the Osps-bearing strain B31 . Not only does this suggest that P13 performs an important function for the survival of Borrelia, but also that in the presence of Osps the P13 epitope accessibility is impaired. It is also noteworthy that in an immunoblot using our polyclonal antiserum against P13, only the two expressed peptide fragments (A and C, Fig. 3 ), which flanked surface-exposed fragment B, were recognized (data not shown). This discrepancy between the behaviour of the two antibodies could be explained by their different modes of development. Our P13 polyclonal antiserum was obtained by immunizing a rabbit with purified P13 (Noppa et al., 2001) and could therefore recognize the entire P13 protein. In contrast, the mAb was raised against whole Borrelia cells, restricting recognition to the natural surface-exposed epitope of P13 . Perhaps the polyclonal antiserum did not recognize the exposed epitope of P13 (fragment B) because of an altered conformation of the artificial peptide or simply because the serum is not specific enough to recognize this small region of the whole protein.
The loss of plasmids during in vitro cultivation is a wellknown phenomenon for Borrelia spirochaetes (Barbour, 1989; Busch et al., 1997; Grimm et al., 2003; McDowell et al., 2001; Norris et al., 1995) , although this is restricted to plasmids harbouring genes whose products are important for infectivity but not in vitro growth Purser & Norris, 2000) . Our results showed that paralogue bba01, situated on the 54 kb linear plasmid (lp54), is not lost during in vitro passage. Moreover, bba01 is also the only paralogue detected in all Lyme disease Borrelia species. These data correlate with earlier studies and indicate that genes situated on plasmid lp54 are not needed for infectivity, but probably play a role during other stages of the Borrelia life cycle (Grimm et al., 2003; Purser & Norris, 2000) . On the other hand, we could show that plasmids lp28-3 and lp28-4 are lost during in vitro cultivation. This indicates that genes situated on these plasmids are not needed for growth of Borrelia in vitro, but could play a role in infectivity and survival of Borrelia in vivo. However, independent studies indicated that B. burgdorferi plasmids lp54 and lp28-3 are not lost during cultivation in vitro (Grimm et al., 2003) and are always present in clones examined after murine infection (Purser & Norris, 2000) . In addition, B. burgdorferi B31 lacking lp28-4 were modestly attenuated in a mouse infection model and carried an important antigen (VraA) for their infectivity in rabbits ). This correlates with our finding that the bbi31 gene situated on this plasmid is transcribed in mice, while neither bba01 nor bbh41 was (Table 5) . Taken together, however, these data contradict another study in which it was concluded that lp28-4 is not needed during infection of mice (Purser & Norris, 2000) . Perhaps the different model systems used for the investigation of plasmid stability could explain these controversies. Nevertheless, the results also show that Borrelia is a complicated organism requiring a distinct plasmid content during different stages of its life cycle.
Since almost all plasmids (with exception of lp54) harbouring the investigated paralogous genes of family 48 are lost during cultivation, they are probably not needed for growth of B. burgdorferi in vitro, but could be needed for their pathogenicity. To investigate the possible function(s) of the paralogue proteins of family 48, we therefore analysed expression of p13 and its paralogues in laboratory culture and during murine infection. Our results showed that the p13 and bbi31 are transcribed in both conditions, while all the other paralogous genes are only transcribed during in vitro culture and are below the detectable level in mice (Tables 4 and 5) . Thus, our RT-PCR results indicate that the P13 and BBI31 proteins could be needed during the infection process and may constitute important virulence factors of Borrelia.
Our sequencing data for the bba01 gene from B. burgdorferi strains B31, N40 and Sh2-82 have revealed sequence homology with two earlier published B. burgdorferi N40 genes, p11 and p5, located in an operon on lp54 (Feng et al., 1996) . The analysis of the genome sequence of B. burgdorferi B31 showed that the p11 and p5 genes were absent; instead the bba01 gene was defined (Fraser et al., 1997) . In the study by Feng et al. (1996) a deletion of one nucleotide in the gene sequence had apparently led to the frameshift and a stop codon. Our sequencing data of the bba01 gene from B. burgdorferi strains B31, N40 and Sh2-82 and the published B. burgdorferi B31 genome sequence have revealed that there is no frameshift in that particular region in any of these strains (data not shown). Therefore, the results presented in that study were confused by a single nucleotide deletion and are not due to a difference between the two B. burgdorferi strains B31 and N40.
The immune serum against the BBA01 paralogue was used to analyse BBA01 synthesis during in vitro culture of Lyme disease Borrelia (Fig. 4) . Expression could not be detected in high-passage strain B31, although the plasmid and the gene are still present (Table 1) . Interestingly, we could detect BBA01 in another high-passage strain, B31-A. This indicates that BBA01 synthesis is downregulated in continuously cultured B. burgdorferi B31, but not in B31-A. This could be explained by different plasmid content or maybe loss of some regulator for the BBA01 protein expression in B. burgdorferi B31 during in vitro propagation. This also supports the idea that P13 paralogues are not needed for growth of Borrelia in vitro but could be important during infection or survival in vivo. Surprisingly, we could not detect BBA01 in outer-membrane preparations of low-passage B31, although we expected that it could be an integral outer-membrane protein like P13 (Noppa et al., 2001) . This might suggest different subcellular localizations of BBA01 and P13 or that BBA01 is rapidly degraded during preparation of the outer-membrane proteins. We also observed that the highest levels of BBA01 are found in B. afzelii strain ACAI, perhaps reflecting an important role for this protein in this Lyme-disease-species. However, we can not rule out that the epitope of BBA01 from ACAI is recognized by the polyclonal antiserum more efficiently. Finally, we have shown that the BBA01 paralogue is expressed in all three Lyme-disease-causing species. Interestingly, BBA01 synthesis is upregulated in the P13 knockout compared to the wild-type (Fig. 4 , lanes 5 and 6), which suggests that BBA01 could possibly compensate for the function of P13. The results also showed that polyclonal antibodies raised against the synthetic peptide of BBA01 are specific, such that the region used to synthesize the peptide could be the epitope of BBA01. Further studies are needed to elucidate this possibility.
It has been postulated that B. burgdorferi has evolved many plasmids and paralogous gene families to be capable of adaptation to different environments (Ojaimi et al., 2003) . Within this theme, we have shown that all investigated paralogues of family 48 can be expressed, but under different conditions, some of which are difficult to mimic in vitro.
We also present a model of the P13 architecture in the outer membrane of B. burgdorferi, although more studies on the structure of this protein are required. Taking the results together, we have shown that the paralogue family 48 has at least two members (P13 and BBA01) that are synthesized during laboratory cultivation. Conversely, p13 and bbi01 are transcribed in mice and could therefore be important during establishment of infection in animals.
In this context, we believe that altered expression of the various paralogues is important during adaptation to different environments. Upregulation of the BBA01 protein in the p13 knockout strain indicates that paralogues not only have sequence homology, but also could exhibit some functional redundancy. Since Borrelia has no advanced metabolic capacity and obtains all the essential nutrients from the haemolymph of ticks or the blood of mammals, an efficient and selective uptake mechanism, such as porins, is required. Earlier, we established that P13 is a channelforming protein (Ö stberg et al., 2002) . It is also evident that BBA01 is expressed in vitro and is apparently processed in a similar manner to P13. In addition, the gene is present in all strains of Lyme disease Borrelia investigated. Therefore, we propose that the BBA01 paralogue could also be a channel-forming protein, needed at certain stages of the Borrelia life cycle. Further studies are needed to investigate this possibility. Moreover, expression of the paralogues in different environments, in both ticks and different animals, may give a better understanding of the biology of Borrelia spirochaetes and the pathogenesis during Lyme disease infection.
